New pill aims to tame severe skin Flare-Ups
NCT ID NCT07204639
Summary
This study is testing a new oral medication called RAP-103 to see if it can reduce the severity of psoriasis and improve patients' quality of life. It will involve about 90 adults with moderate-to-severe plaque psoriasis, who will take either the drug at one of two doses or a placebo pill for 8 weeks. Researchers will measure how much the skin clears and monitor for side effects to see if the treatment is safe and effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Innovacion y Desarrollo de Estrategias en Salud
Mexico City, Mexico City, 14320, Mexico
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.